Curium in the United Kingdom & Ireland A legacy of excellence in nuclear medicine

In the UK & Ireland, Curium supports healthcare professionals with high-quality radiopharmaceutical solutions for diagnostic imaging and scale up our diagnostics and into radiotherapeutics when appropriate. With an MIA recently issued for both our newly opened site in Oxford and Hammersmith, we provide access to diagnostics nationwide and are set up to grow the business and scale up into targeted therapies.

100+

Dedicated employees

About Curium in the United Kingdom & Ireland

In the UK, Curium is a member of the Ethical Medicines Industry Group

We have a strong legacy of supplying both SPECT and PET radiopharmaceuticals to nuclear medicine sites nationwide. We work closely with hospitals, imaging centres, nuclear medicine specialists and other healthcare professionals to provide high-quality diagnostic radiopharmaceutical solutions, ensure reliable supply and support high standards of patient care.

With strong regulatory expertise, reliable distribution, and a commitment to quality and safety, Curium plays an important role in ensuring consistent access to nuclear medicine products that support patient diagnosis and treatment across both countries.

Curium Products in the United Kingdom & Ireland

Comprehensive radiopharmaceutical portfolio

Curium offers innovative radiopharmaceutical solutions designed to support accurate diagnosis in nuclear medicine. Key products such as Pylclari and Pylclari AI which helps healthcare professionals improve imaging efficiency, clinical decision-making, and patient care through advanced diagnostic technologies.

ERtracER

ERtracER Solution for Injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

ERtracER in Ireland

Product information

ERtracER in United Kingdom

Product information

GalenVita

GalenVita 0.74 –3.70 GBq radionuclide generator

Active ingredient

Germanium (68Ge) chloride / gallium (68Ga) chloride

Disease area

Radionuclide Generators

Available in

GalenVita in Ireland

Product information

Gallium (67Ga) Citrate

Gallium Citrate Ga 67 Injection

Active ingredient

Gallium citrate Ga 67

Disease area

Infectious Diseases, Oncology, Pulmonology

Available in
, 

Gallium (67Ga) Citrate in Ireland

Product information

Gallium (67Ga) Citrate in United Kingdom

Product information

Indium (111In) Chloride

Indium (111In) Chloride Curiumpharma 370 MBq/ml radiopharmaceutical precursor

Active ingredient

In111-chloride

Disease area

Infectious Diseases, Oncology

Available in
, 

Indium (111In) Chloride in Ireland

Product information

Indium (111In) Chloride in United Kingdom

Product information

Indium (111In) DTPA

Indium (111In) DTPA 37 MBq/mL solution for injection

Active ingredient

In111-pentetate

Disease area

Neurology

Available in
, 

Indium (111In) DTPA in Ireland

Product information

Indium (111In) DTPA in United Kingdom

Product information

KryptoScan

KryptoScan 75-740 MBq radionuclide generator

Active ingredient

rubidium (81Rb)/krypton (81mKr)

Disease area

Pulmonology, Radionuclide Generators

Available in
, 

KryptoScan in Ireland

Product information

KryptoScan in United Kingdom

Product information

MIBG (I123)

MIBG (123.I) 74 MBq/mL solution for injection

Active ingredient

Iobenguane

Disease area

Oncology

Available in
, 

MIBG (I123) in Ireland

Product information

MIBG (I123) in United Kingdom

Product information

Octreoscan™

(kit for the preparation of indium In 111 pentetreotide injection)

Active ingredient

In111-pentetreotide

Disease area

Oncology

Available in
, 

Octreoscan™ in Ireland

Product information

Octreoscan™ in United Kingdom

Product information

Pulmocis®

Human albumin as macroaggregates 2 mg, kit for radiopharmaceutical preparation

Active ingredient

macroaggregated human albumin (macrosalb)

Disease area

Pulmonology

Available in
, 

Pulmocis® in Ireland

Product information

Pulmocis® in United Kingdom

Product information

Quadramet®

Quadramet, 1.3 GBq/mL solution for injection

Active ingredient

Sm153-lexidronam

Disease area

Oncology

Available in
, 

Quadramet® in Ireland

Product information

Quadramet® in United Kingdom

Product information

Renocis®

kit for radiopharmaceutical preparation

Active ingredient

Succimer (dimercaptosuccinic acid)

Disease area

Nephrology

Available in
, 

Renocis® in Ireland

Product information

Renocis® in United Kingdom

Product information

Sodium Iodide I-131 Capsules Therapeutic

Sodium Iodide (131I) Capsules T 37-7400 MBq/mL hard capsule

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I-131 Capsules Therapeutic in Ireland

Product information

Sodium Iodide I-131 Capsules Therapeutic in United Kingdom

Product information

Sodium Iodide I123 Injection

Sodium iodide (123I) 37 MBq/mL solution for injection

Active ingredient

I123-sodium

Disease area

Endocrinology, Oncology

Available in

Sodium Iodide I123 Injection in United Kingdom

Product information

Stamicis®

Stamicis 1 mg kit for radiopharmaceutical preparation

Active ingredient

[tetrakis (2-methoxyisobutyl isonitrile) copper (I)] tetrafluoroborate (sestamibi)

Disease area

Cardiology

Available in
, 

Stamicis® in Ireland

Product information

Stamicis® in United Kingdom

Product information

Striascan™

Striascan 74 MBq/mL solution for injection

Active ingredient

I123-ioflupane

Disease area

Neurology

Available in
, 

Striascan™ in Ireland

Product information

Striascan™ in United Kingdom

Product information

Technescan™ DMSA

Technescan DMSA 1.2 mg kit for radiopharmaceutical preparation

Active ingredient

Succimer (dimercaptosuccinic acid)

Disease area

Nephrology

Available in

Technescan™ DMSA in Ireland

Product information

Technescan™ DTPA

TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation

Active ingredient

Pentetic acid

Disease area

Nephrology, Neurology, Pulmonology, Urology

Available in
, 

Technescan™ DTPA in Ireland

Product information

Technescan™ DTPA in United Kingdom

Product information

Technescan™ HDP

(Kit for the Preparation of Technetium Tc 99m Oxidronate Injection)

Active ingredient

Sodium oxidronate

Disease area

Musculoskeletal

Available in
, 

Technescan™ HDP in Ireland

Product information

Technescan™ HDP in United Kingdom

Product information

Technescan™ MAG3

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Mertiatide

Disease area

Nephrology, Urology

Available in
, 

Technescan™ MAG3 in Ireland

Product information

Technescan™ MAG3 in United Kingdom

Product information

Technescan™ PYP

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Sodium pyrophosphate

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Technescan™ PYP in Ireland

Product information

Technescan™ PYP in United Kingdom

Product information

Technescan™ Sestamibi

Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation

Active ingredient

[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate

Disease area

Cardiology, Endocrinology, Oncology

Available in
, 

Technescan™ Sestamibi in Ireland

Product information

Technescan™ Sestamibi in United Kingdom

Product information

Thallous Chloride Tl 201 Injection

Thallous Chloride Tl 201 Injection

Active ingredient

Tl201-Chloride

Disease area

Cardiology, Endocrinology

Available in
, 

Thallous Chloride Tl 201 Injection in Ireland

Product information

Thallous Chloride Tl 201 Injection in United Kingdom

Product information

Ultra Technekow™ FM

Ultra-Technekow FM 2.15-43.00 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Ultra Technekow™ FM in Ireland

Product information

Ultra Technekow™ FM in United Kingdom

Product information

Ireland online ordering and product release system

Curium operates a fully validated online ordering and product release system for radiopharmaceuticals, compliant with 21 CFR Part 11 and EudraLex Annex 11. The platform allows users to place orders, manage deliveries, track order status, access product release certificates, receive automated notifications throughout the product lifecycle, and instantly acknowledge product receipt through secure online access.

Curium UK updates its Carbon Reduction Plan and reaffirms its Net Zero ambition

Curium UK is committed to reducing the carbon emissions associated with its operations and value chain.
Our updated Carbon Reduction Plan sets out the actions being taken to reduce emissions across our UK activities. It supports our ambition to achieve Net Zero emissions by 2045, in line with the NHS Net Zero Supplier Roadmap.

Modern Slavery Statement – UK

This Modern Slavery Statement sets out Curium Pharma UK Ltd.’s commitment to conduct business in a responsible and ethical manner, with respect for internationally recognized human rights, as well as the measures taken to prevent modern slavery and human trafficking in its operations and supply chains.

Curium Locations in the United Kingdom and Ireland

Dublin

Location type

Sales Offices

Address
Blackrock Clinic, Blackrock,
Dublin, Ireland
A94 E4X7

London

Location type

Country Headquarters

Address
100 Pall Mall
London SW1Y 5NQ
United Kingdom

London (Hammersmith)

Location type

SPECT Radiopharmacies

Address
Hammersmith Radiopharmacy
Burlington Danes Building
Imperial College London (Hammersmith Campus)
Du Cane Road
London W12 0NN
UK

London (University College Hospital)

Location type

PET Radiopharmacies

Address
University College London Hospital
235 Euston Road
London NW1 2BU
UK

Oxford

Location type

SPECT Radiopharmacies

Address
Oxford Radiopharmacy
The Radiopharmacy Unit, Block 4
The Churchill Hospital
Headington
Oxford OX3 7LE
United Kingdom

Portsmouth

Location type

Sales Offices

Address
211b Central, Second Floor, Building 1000
Lakeside, North Harbour
Western Road, Portsmouth
Hampshire PO6 3EN
United Kingdom